Pedro Herranz Pinto (P Herranz, P Herranz-Pinto, P Herranz Pinto, Pedro Herranz, Pedro Herranz-Pinto)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Venues

Clinical drug investigation

The British journal of dermatology

Dermatology and therapy

Journal of the European Academy of Dermatology and Venereology : JEADV

Hospital Universitario La Paz

Autonomous University Madrid (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Universitario La Paz Jan 09 2016

Spain

Head of Department :: Dermatology

Education History

Autonomous University Madrid Dec 01 2012

Spain

PHD :: Medicine

Publications

Rafaela M Souza, Regina Chahine Chater, Isabela Reis Marques, Yasmin Luz Lima Mesquita, Rubiana Sarto, Izadora Lapenda, Lívia Figueiredo Pereira, Luana Moury, Pedro Herranz Pinto
Efficacy and Safety of Topical Roflumilast for the Treatment of Psoriasis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clinical drug investigation (2024)
Pedro Herranz Pinto, Maria Luisa Alonso-Pacheco, Rosa Feltes-Ochoa, Ander Mayor-Ibarguren, Guillermo Servera-Negre, Jose Manuel Busto-Leis, Maria Angeles Gonzalez-Fernández, Alicia Herrero-Ambrosio
Real-world Performance of a New Strategy for Off-Label Use of Guselkumab in Moderate to Severe Psoriasis: Super-Responder Patients as the Epitome of Efficacy and Optimisation. Clinical drug investigation (2023)
Carmen Busca, Lucia Quintana-Castanedo, Clara Chiloeches Fernández, Daniel Nieto Rodríguez, Pedro Herranz Pinto, Ana Belén Delgado Hierro, Antonio Olveira Martín, María Luisa García Montes
Psoriasis and Liver Damage in HIV-Infected Patients. Cells 10 (5) (2021)
Gil Yosipovitch, Marjolein de Bruin-Weller, April W Armstrong, Jashin J Wu, Pedro Herranz Pinto, Diamant Thaҫi, Dimittri Delevry, Gaëlle Bégo-Le Bagousse, Raymond Zhang, Brad Shumel, Ana Beatris Rossi, Jingdong Chao
Dupilumab Treatment Provides Sustained Improvements Over 2 Years in Symptoms and Quality of Life in Adults with Atopic Dermatitis. Dermatology and therapy 11 (6) (2021)
Jose Manuel Busto Leis, Guillermo Servera, Ander Mayor, E Sendagorta-Cudós, Marta Feito-Rodríguez, Almudena Nuno-Gonzalez, M D Montero-Vega, Pedro Herranz Pinto
Pityriasis rosea, COVID-19 and vaccination: new keys to understand an old acquaintance. Journal of the European Academy of Dermatology and Venereology : JEADV 35 (8) (2021)
Andreas Wollenberg, Andrew Blauvelt, Emma Guttman-Yassky, Margitta Worm, C Lynde, Jean-Philippe Lacour, Lynda Spelman, Norito Katoh, Hidehisa Saeki, Y Poulin, A Lesiak, Leon Kircik, S H Cho, Pedro Herranz Pinto, Michael J Cork, Ketty Peris, L A Steffensen, B Bang, A Kuznetsova, T N Jensen, M L Østerdal, E L Simpson, null null
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2). The British journal of dermatology 184 (3) (2020)
Antonio Olveira, Pedro Herranz Pinto, María Luisa Montes
Psoriasis and fatty liver: a harmful synergy. Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva 111 (4) (2020)
Almudena Nuno-Gonzalez, P Martin-Carrillo, K Magaletsky, M D Martin Rios, C Herranz Mañas, J Artigas Almazan, Gonzalo García De Casasola-Sánchez, E Perez Castro, A Gallego Arenas, A Mayor Ibarguren, Marta Feito-Rodríguez, Belén Lozano-Masdemont, M Beato, E Ruiz Bravo, P Oliver, M D Montero Vega, Pedro Herranz Pinto
Prevalence of mucocutaneous manifestations in 666 patients with COVID-19 in a field hospital in Spain: oral and palmoplantar findings. The British journal of dermatology 184 (1) (2020)

Pedro Herranz Pinto.css-eqlu8i{font-size:small;padding-left:4px;} (P Herranz, P Herranz-Pinto, P Herranz Pinto, Pedro Herranz, Pedro Herranz-Pinto)

Publication Activity (10 Years)

Top Topics

Top Venues

Pedro Herranz Pinto (P Herranz, P Herranz-Pinto, P Herranz Pinto, Pedro Herranz, Pedro Herranz-Pinto)